World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
21302
World Ranking
18444
National Ranking
9201

Karen H. Antman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Karen H. Antman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 233 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Karen H. Antman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Karen H. Antman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2011 - Member of the National Academy of Medicine (NAM)
  • 1997 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Karen H. Antman is affiliated with Boston University in the United States. Their academic career is marked by recognition through several professional honors, reflecting contributions to the medical and scientific community.

They are a member of the National Academy of Medicine (NAM) since 2011. This membership indicates a significant professional standing in health and medicine fields. Additionally, they have been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 1997. They are also a member of the Association of American Physicians, underscoring involvement in a professional organization dedicated to advancing medical knowledge.

While specific details about their recent papers, co-authors, publication venues, book publications, fields of study, subfields, and main research topics were not provided, their affiliations and honors suggest a significant presence in medical research and clinical practice.

Best Publications

  • Kaposi's Sarcoma

    Karen Antman;Yuan Chang

  • Imatinib Mesylate — A New Oral Targeted Therapy

    David G Savage;Karen H Antman

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

    Karen S. Antman;James D. Griffin;Anthony Elias;Mark A. Socinski

  • An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

    K Antman;J Crowley;S P Balcerzak;S E Rivkin

  • Serotherapy of a Patient with a Monoclonal Antibody Directed against a Human Lymphoma-associated Antigen

    Lee M. Nadler;Philip Stashenko;Russell Hardy;William D. Kaplan

  • Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

    T S Frank;S A Manley;O I Olopade;S Cummings

  • A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

    K Antman;L Ayash;A Elias;C Wheeler

  • Introduction: the history of arsenic trioxide in cancer therapy.

    Karen H. Antman

  • High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

    K. H. Antman;P. A. Rowlings;W. P. Vaughan;C. J. Pelz

  • Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.

    K Antman;R Shemin;L Ryan;K Klegar

  • International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.

    Margaret A. Shipp;M. D. Abeloff;K. H. Antman;G. Carroll

  • Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

    Anthony Elias;Louise Ryan;Aaron Sulkes;Jerry Collins

  • Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

    Charles Hesdorffer;Janet Ayello;Maureen Ward;Andreas Kaubisch

  • Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma

    D J Sugarbaker;G M Strauss;T J Lynch;W Richards

  • Multimodality therapy for malignant mesothelioma based on a study of natural history.

    Karen Hamm Antman;Ronald H. Blum;Joel S. Greenberger;Gordon Flowerdew

  • Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

    Karen H. Antman;Louise Ryan;Anthony Elias;Debra Sherman

  • Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

    V R Grann;K S Panageas;W Whang;K H Antman

  • The Role of Cytologic Evaluation of Pleural Fluid in the Diagnosis of Malignant Mesothelioma

    Andrew A. Renshaw;Barbara R. Dean;Karen H. Antman;David J. Sugarbaker

  • Microangiopathic hemolytic anemia and cancer: a review.

    Karen Hamm Antman;Arthur T. Skarin;Robert J. Mayer;Hilary K. Hargreaves

Frequent Co-Authors

Anthony D. Elias
Anthony D. Elias University of Colorado Boulder
Joel S. Greenberger
Joel S. Greenberger University of Pittsburgh
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Gary E. Schwartz
Gary E. Schwartz University of Arizona
George P. Canellos
George P. Canellos Harvard University
Colin B. Begg
Colin B. Begg Memorial Sloan Kettering Cancer Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Alfred I. Neugut
Alfred I. Neugut Columbia University
Lee M. Nadler
Lee M. Nadler Harvard University
Robert W. Finberg
Robert W. Finberg University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine-related fields in the USA opens doors to diverse online degree opportunities and alternative career routes. One popular choice is nursing. For those starting from scratch, online adn programs for non nurses offer a flexible pathway to join this high-demand profession, making it more accessible for career changers.

Another in-demand option is financial aid for medical billing and coding online classes, which can make it easier for students to train in essential administrative healthcare roles while minimizing financial stress.

For those interested in practical nursing, many schools have become more flexible with entry requirements. Some offer lpn school without teas test entrance, helping students bypass standard exam barriers and get started sooner.

Alternatively, if you’re considering a leadership path in healthcare, accelerated healthcare administration degree online programs allow motivated students to quickly gain credentials for managerial roles in hospitals and clinics.

Best Scientists Citing Karen H. Antman

Trending Scientists

Recently Published Articles